| __timestamp | Bristol-Myers Squibb Company | Insmed Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 4534000000 | 56292000 |
| Thursday, January 1, 2015 | 5920000000 | 74277000 |
| Friday, January 1, 2016 | 4940000000 | 122721000 |
| Sunday, January 1, 2017 | 6411000000 | 109749000 |
| Monday, January 1, 2018 | 6345000000 | 145283000 |
| Tuesday, January 1, 2019 | 6148000000 | 131711000 |
| Wednesday, January 1, 2020 | 11143000000 | 181157000 |
| Friday, January 1, 2021 | 10195000000 | 272744000 |
| Saturday, January 1, 2022 | 9509000000 | 397518000 |
| Sunday, January 1, 2023 | 9299000000 | 571011000 |
| Monday, January 1, 2024 | 11159000000 |
Unleashing the power of data
In the competitive world of pharmaceuticals, innovation is key. Bristol-Myers Squibb Company and Insmed Incorporated are two players with distinct strategies. Over the past decade, Bristol-Myers Squibb has consistently outpaced Insmed in research and development (R&D) spending. In 2023, Bristol-Myers Squibb invested approximately 16 times more in R&D than Insmed, highlighting their commitment to innovation.
From 2014 to 2023, Bristol-Myers Squibb's R&D expenses grew by over 100%, peaking in 2020 with a 150% increase from 2014. Meanwhile, Insmed's R&D spending, though smaller, showed a steady upward trend, increasing by nearly 900% over the same period. This growth reflects Insmed's strategic focus on niche markets and specialized treatments.
As the pharmaceutical landscape evolves, these investment patterns reveal the companies' differing approaches to innovation and market leadership.
Who Prioritizes Innovation? R&D Spending Compared for Merck & Co., Inc. and Insmed Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Bristol-Myers Squibb Company
Bristol-Myers Squibb Company vs Gilead Sciences, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Bristol-Myers Squibb Company and Zoetis Inc. Allocate Funds
Bristol-Myers Squibb Company or BeiGene, Ltd.: Who Invests More in Innovation?
Comparing Innovation Spending: Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Alkermes plc
Comparing Innovation Spending: Bristol-Myers Squibb Company and Catalyst Pharmaceuticals, Inc.
Gilead Sciences, Inc. vs Insmed Incorporated: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Viatris Inc. vs Insmed Incorporated
Analyzing R&D Budgets: Insmed Incorporated vs Sarepta Therapeutics, Inc.
Comparing Innovation Spending: Insmed Incorporated and Ligand Pharmaceuticals Incorporated